Pilatus Biosciences
PrivateLast Round
Pre Seed
Dec 15, 2025
Total Funding Raised
$14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pilatus Biosciences operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Pre Seed round in December 2025.
Pilatus Biosciences is a biotechnology company that develops first-in-class antibodies and bifunctional proteins targeting metabolic checkpoints to reprogram the tumor microenvironment for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pilatus Biosciences Comparables
Compare Pilatus Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeoTrail Therapeutics, Inc. | 78% | |
| Elixiron Immunotherapeutics | 69% | |
| ImCare Biotech, Inc. | 68% |
For institutional investors. Book with your work email.
Pilatus Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Pilatus Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiger Jade Pebble Accelerator | Pre Seed |
| Cancer Research Institute | Pre Seed |
| Mosaic Venture Lab | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 10, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Apr 23, 2026
Monthly visitors increased 37% to 2.6K.
For institutional investors. Book with your work email.
Pilatus Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pilatus Biosciences's valuation, stock price, and market status.
Is Pilatus Biosciences a public or private company?
Pilatus Biosciences is a private company.
What is the current stock price of Pilatus Biosciences?
Pilatus Biosciences is a private company, so its shares have no public market price. Caplight tracks Pilatus Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pilatus Biosciences worth (valuation)?
Valuation information for Pilatus Biosciences is not publicly available.
Can I buy Pilatus Biosciences stock?
Pilatus Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pilatus Biosciences's last funding round?
Pilatus Biosciences's most recent funding round was Pre Seed on December 15, 2025.
Who are the main investors in Pilatus Biosciences?
Key investors in Pilatus Biosciences include Tiger Jade Pebble Accelerator, Cancer Research Institute, Mosaic Venture Lab.
Will Pilatus Biosciences IPO soon?
No public IPO plans have been announced for Pilatus Biosciences.
How can I track Pilatus Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Pilatus Biosciences's shares on secondary markets.